Aspen bags Covid-19 vaccine deal with Johnson & Johnson
Agreement will enable drugmaker to use spare manufacturing capacity and bring down overhead costs, says CEO
SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has signed a preliminary agreement to produce the candidate Covid-19 vaccine being developed by US drugmaker Johnson & Johnson (J&J) at its Port Elizabeth site, it announced on Monday.
The news was cheered by shareholders, who boosted Aspen’s share price by up to 11.5% in intraday trading, its biggest daily gain since April 18. Its share price closed at R117.65, its highest since October 1...